Case Report

The Journal of the Korean Rheumatism Association 2007; 14(4): 431-435

Published online December 30, 2007

© Korean College of Rheumatology

Isoniazid에 의해 유발된 약물 유도성 루푸스 1예

오성렬ㆍ조미영ㆍ류한승ㆍ이재훈ㆍ조해중*ㆍ최민규**ㆍ오재민**ㆍ안선호ㆍ송주흥ㆍ이명수

원광대학교 의과대학 내과학교실, 산부인과학교실*, 해부학교실**

A Case of Isoniazid Induced Systemic Lupus Erythematosus

Seong Rheol Oh, M.D., Meyoung Cho, M.D., Han Seung Ryu, M.D., Jae Hun Lee, M.D., Hae Joong Cho, M.D.*, Min Kyu Choi, M.D.**, Jae Min Oh, M.D.**, Sun Ho Ahn, M.D., Ju Hung Song, M.D., Myeung Su Lee, M.D.

Departments of Internal Medicine, Obstetrics and Gynecology*, and Anatomy**, School of Medicine, Wonkwang University, Iksan, Korea

Correspondence to : Myeung Su Lee

Abstract

Many drugs have been known to induce lupus-like syndrome, composing approximately 10% of all SLE cases. Isoniazid-induced lupus erythematosus affects either sex equally and the most common presenting feature is arthralgia or arthritis with anemia. Fever and pleuritis occur in approximately half of the cases, and pericarditis in approximately 30% of cases. We discribe a 28-year-old woman receiving antituberculous medications including isoniazid for one month. She was hospitalized with fever, arthralgia and newly developed pleural effusion The analysis of pleural fluid and serum revealed an elevated level of antinuclear antibody. We suspected of drug induced lupus and stopped isoniazid medication. After discontinuation of isoniazid and short course of prednisolone treatment, her symptoms and pleural effusion disappeared. This case is to our knowledge, the fist report of isoniazid induced SLE in Korea.

Keywords Systemic lupus erythematosus, Isoniazid, Drug

Article

Case Report

The Journal of the Korean Rheumatism Association 2007; 14(4): 431-435

Published online December 30, 2007

Copyright © Korean College of Rheumatology.

Isoniazid에 의해 유발된 약물 유도성 루푸스 1예

오성렬ㆍ조미영ㆍ류한승ㆍ이재훈ㆍ조해중*ㆍ최민규**ㆍ오재민**ㆍ안선호ㆍ송주흥ㆍ이명수

원광대학교 의과대학 내과학교실, 산부인과학교실*, 해부학교실**

A Case of Isoniazid Induced Systemic Lupus Erythematosus

Seong Rheol Oh, M.D., Meyoung Cho, M.D., Han Seung Ryu, M.D., Jae Hun Lee, M.D., Hae Joong Cho, M.D.*, Min Kyu Choi, M.D.**, Jae Min Oh, M.D.**, Sun Ho Ahn, M.D., Ju Hung Song, M.D., Myeung Su Lee, M.D.

Departments of Internal Medicine, Obstetrics and Gynecology*, and Anatomy**, School of Medicine, Wonkwang University, Iksan, Korea

Correspondence to:Myeung Su Lee

Abstract

Many drugs have been known to induce lupus-like syndrome, composing approximately 10% of all SLE cases. Isoniazid-induced lupus erythematosus affects either sex equally and the most common presenting feature is arthralgia or arthritis with anemia. Fever and pleuritis occur in approximately half of the cases, and pericarditis in approximately 30% of cases. We discribe a 28-year-old woman receiving antituberculous medications including isoniazid for one month. She was hospitalized with fever, arthralgia and newly developed pleural effusion The analysis of pleural fluid and serum revealed an elevated level of antinuclear antibody. We suspected of drug induced lupus and stopped isoniazid medication. After discontinuation of isoniazid and short course of prednisolone treatment, her symptoms and pleural effusion disappeared. This case is to our knowledge, the fist report of isoniazid induced SLE in Korea.

Keywords: Systemic lupus erythematosus, Isoniazid, Drug

JRD
Jan 01, 2025 Vol.32 No.1, pp. 1~7
COVER PICTURE
Cumulative growth of rheumatology members and specialists (1980~2024). Cumulative distribution of the number of the (A) Korean College of Rheumatology members and (B) rheumatology specialists. (J Rheum Dis 2025;32:63-65)

Stats or Metrics

Share this article on

  • line

Related articles in JRD

Journal of Rheumatic Diseases

pISSN 2093-940X
eISSN 2233-4718
qr-code Download